Trials / Completed
CompletedNCT00214630
LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
A 12-week Randomized, Open-label 3-arm, Parallel Group, Multicenter Phase IIIb Study Comparing Efficacy and Safety of Rosuvastatin 20mg and 40mg With That of Atorvastatin 80 mg in Subjects With Acute Coronary Syndromes
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 825 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rosuvastatin calcium | |
| DRUG | atorvastatin |
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2005-09-22
- Last updated
- 2010-11-19
Locations
56 sites across 5 countries: United States, Costa Rica, El Salvador, Morocco, Panama
Source: ClinicalTrials.gov record NCT00214630. Inclusion in this directory is not an endorsement.